Tao Zhang

Dr. Tao Zhang

School of Food Science and Environmental Health, Technological University Dublin, Dublin, Ireland
+1
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Tao ZhangTao Zhang
Tao Zhang
DFDeirdre Frances Finn
Deirdre Frances Finn
JBJames Barlow
James Barlow
JWJohn Jarlath Walsh
John Jarlath Walsh

6 January 2023 in Food Science & Nutrition
Verified
Journal Article
Open access
QYQuanxiang Yan
Quanxiang Yan
Tao ZhangTao Zhang
Tao Zhang
COChristine O'Connor
Christine O'Connor
JBJames Barlow
James Barlow
JWJohn Walsh
John Walsh
HSHelen Sheridan
Helen Sheridan
Vitamin K1 (VitK1) and Vitamin K2 (VitK2), two important naturally occurring micronutrients in the VitK family, found, respectively, in green leafy plants and algae (VitK1) and animal and fermented foods (VitK2). The present review explores the multiple biological functions of VitK2 from recently published in vitro and in vivo studies, including promotion of osteogenesis, prevention of calcification, relief of menopausal symptoms, enhancement of mitochondrial energy release, hepato‐ and neuro‐protective effects, and possible use in treatment of coronavirus disease. The mechanisms of action associated with these biological effects are also explored. Overall, the findings presented here suggest that VitK, especially VitK2, is an important nutrient family for the normal functioning of human health. It acts on almost all major body systems and directly or indirectly participates in and regulates hundreds of physiological or pathological processes. However, as biological and clinical data are still inconsistent and conflicting, more in‐depth investigations are warranted to elucidate its potential as a therapeutic strategy to prevent and treat a range of disease conditions.

24 May 2024 in Foods
Verified
Journal Article
Open access
PDF file
Tao ZhangTao Zhang
Tao Zhang
COChristine O'Connor
Christine O'Connor
HSHelen Sheridan
Helen Sheridan
JBJames Barlow
James Barlow
Vitamins are essential organic compounds that vary widely in chemical structure and are vital in small quantities for numerous biochemical and biological functions. They are critical for metabolism, growth, development and maintaining overall health. Vitamins are categorised into two groups: hydrophilic and lipophilic. Vitamin K (VK), a lipophilic vitamin, occurs naturally in two primary forms: phylloquinone (VK1), found in green leafy vegetables and algae, and Menaquinones (VK2), present in certain fermented and animal foods and widely formulated in VK supplements. This review explores the possible factors contributing to VK deficiency, including dietary influences, and discusses the pharmacological and therapeutic potential of supplementary VK2, examining recent global clinical studies on its role in treating diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, cardiovascular disease, chronic kidney disease, diabetes, neurodegenerative disorders and cancers. The analysis includes a review of published articles from multiple databases, including Scopus, PubMed, Google Scholar, ISI Web of Science and CNKI, focusing on human studies. The findings indicate that VK2 is a versatile vitamin essential for human health and that a broadly positive correlation exists between VK2 supplementation and improved health outcomes. However, clinical data are somewhat inconsistent, highlighting the need for further detailed research into VK2′s metabolic processes, biomarker validation, dose–response relationships, bioavailability and safety. Establishing a Recommended Daily Intake for VK2 could significantly enhance global health.

21 May 2025 in Drug Discovery Today
Verified
Journal Article
Open access
SZShengxin Zhang
Shengxin Zhang
Tao ZhangTao Zhang
Tao Zhang
Gemma KinsellaGemma Kinsella
Gemma Kinsella
JCJames F. Curtin
James F. Curtin
The standard treatments for prostate cancer (PCa) include chemotherapy, hormone therapy, targeted therapies based on androgen receptor (AR) and/or gonadotropin-releasing hormone (GnRH) receptor antagonists, and radiation therapy. But PCa therapeutic resistance remains an unsolved challenge, leading to progression to castration-resistant prostate cancer (CRPC). Emerging PCa therapies - including poly(ADP-ribose) polymerase (PARP) inhibitors, AR crosstalk signalling pathway inhibitors, B-cell lymphoma 2 (BCL-2) inhibitors, cyclin-dependent kinase 4 (CDK4)/CDK6 inhibitors, CRISPR/Cas9, epigenetic inhibitors, and nanotechnology-based drug-delivery approaches - provide promising targeted solutions. Targeted protein degradation therapy, particularly AR degradation therapies, effectively inhibits resistance at its source. This review summarises the established and emerging PCa therapies, focusing on discussing their efficacy in terms of PCa resistance with supporting experimental findings and the mechanisms of PCa drug resistance.

1 March 2015 in Journal of Molecular Structure
Verified
Journal Article
Open access
Tao ZhangTao Zhang
Tao Zhang
KPKrzysztof Paluch
Krzysztof Paluch
GSGaia Scalabrino
Gaia Scalabrino
NFNeil Frankish
Neil Frankish
Anne Marie HealyAnne Marie Healy
Anne Marie Healy
HSHelen Sheridan
Helen Sheridan
The single enantiomer (1S,2S)-2-benzyl-2,3-dihydro-2-(1H-inden-2-yl)-1H-inden-l-ol (2), has recently been synthesized and isolated from its corresponding diastereoisomer (1). The molecular and crystal structures of this novel compound have been fully analyzed. The relative and absolute configurations have been determined by using a combination of analytical tools including X-ray crystallography, X-ray Powder Diffraction (XRPD) analysis and Nuclear Magnetic Resonance (NMR) spectroscopy. (C) 2014 The Authors. Published by Elsevier B.V.

1 May 2011 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JBJames Barlow
James Barlow
Tao ZhangTao Zhang
Tao Zhang
OWOrla Woods
Orla Woods
ABAdam J. Byrne
Adam J. Byrne
JWJohn Jarlath Walsh
John Jarlath Walsh
In an investigation of 4-amino-3,4-dihydronaphthalen-1(2H)-ones as novel modulators of allergic and inflammatory phenomena, we have investigated a series of cyclic analogues. Tertiary amines of structural types 9, 10, 20 and 21 were synthesised and evaluated for mast cell stabilising activity. In vitro and in vivo studies showed that of these compounds, the cyclohexenylamino derivatives of tetralone and benzosuberone of series 20 and 21 exhibited interesting activity both in vitro and in vivo.